-
EP2451348
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2451348
| EP2451348 - USE OF VENTRICULAR ENLARGEMENT RATE IN INTRAVENOUS IMMUNOGLOBULIN TREATMENT OF ALZHEIMER'S DISEASE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.03.2017 Database last updated on 06.11.2024 | |
| Former | Examination is in progress Status updated on 28.11.2016 | Most recent event Tooltip | 03.03.2017 | Application deemed to be withdrawn | published on 05.04.2017 [2017/14] | Applicant(s) | For all designated states Baxalta GmbH Thurgauerstrasse 130 8152 Glattpark, Opfikon / CH | For all designated states Baxalta Incorporated 1200 Lakeside Drive Bannockburn, IL 60015 / US | [2015/51] |
| Former [2012/20] | For all designated states Baxter International Inc One Baxter Parkway Deerfield, IL 60015 / US | ||
| For all designated states Baxter Healthcare S.A. Thurgauerstrasse 130 8152 Glattpark (Opfikon) / CH | Inventor(s) | 01 /
RELKIN, Norman R. 53 Eckerson Road Harrington Park New Jersey 07640 / US | [2012/20] | Representative(s) | Hoffmann Eitle, et al Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
| Former [2012/20] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastraße 4 81925 München / DE | Application number, filing date | 11769496.8 | 13.04.2011 | WO2011US32232 | Priority number, date | US20100323739P | 13.04.2010 Original published format: US 323739 P | [2012/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011130355 | Date: | 20.10.2011 | Language: | EN | [2011/42] | Type: | A1 Application with search report | No.: | EP2451348 | Date: | 16.05.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.10.2011 takes the place of the publication of the European patent application. | [2012/20] | Search report(s) | International search report - published on: | US | 20.10.2011 | (Supplementary) European search report - dispatched on: | EP | 28.06.2013 | Classification | IPC: | A61B5/05, A61B5/00 | [2013/31] | CPC: |
A61B5/055 (EP,KR,US);
A61B5/0042 (EP,US);
A61B5/4088 (EP,US);
A61B5/4848 (EP,US);
A61K39/395 (KR);
A61P25/28 (EP);
|
| Former IPC [2012/20] | A61B5/05 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2012/20] | Title | German: | VERWENDUNG DER VENTRIKELVERGRÖSSERUNGSRATE BEI DER INTRAVENÖSEN IMMUNGLOBULINBEHANDLUNG VON MORBUS ALZHEIMER | [2012/20] | English: | USE OF VENTRICULAR ENLARGEMENT RATE IN INTRAVENOUS IMMUNOGLOBULIN TREATMENT OF ALZHEIMER'S DISEASE | [2012/20] | French: | UTILISATION DU TAUX D'AGRANDISSEMENT VENTRICULAIRE DANS LE TRAITEMENT PAR IMMUNOGLOBULINE PAR VOIE INTRAVEINEUSE DE LA MALADIE D'ALZHEIMER | [2012/20] | Entry into regional phase | 09.02.2012 | National basic fee paid | 09.02.2012 | Search fee paid | 09.02.2012 | Designation fee(s) paid | 09.02.2012 | Examination fee paid | Examination procedure | 09.02.2012 | Examination requested [2012/20] | 27.01.2014 | Amendment by applicant (claims and/or description) | 13.03.2014 | Despatch of a communication from the examining division (Time limit: M06) | 10.09.2014 | Reply to a communication from the examining division | 01.11.2016 | Application deemed to be withdrawn, date of legal effect [2017/14] | 29.11.2016 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2017/14] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 13.03.2014 | Fees paid | Renewal fee | 29.04.2013 | Renewal fee patent year 03 | 28.04.2014 | Renewal fee patent year 04 | 27.04.2015 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 30.04.2016 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2009017467 (ELAN PHARMA INT LTD [IE], et al); | [Y]US2009155256 (BLACK RONALD [US], et al); | [A] - NESTOR ET AL., "Ventricular enlargement as a possible measure of Alzheimers disease progression validated using the Alzheimer?s disease neuroimaging initiative database", BRAIN, (2008), vol. 131, no. 9, pages 2443 - 2454, XP008150639 DOI: http://dx.doi.org/10.1093/brain/awn146 | [YP] - EVANS, "IVIG Reduced Brain Atrophy in Alzheimer's", CLINICAL PSYCHIATRY NEWS, (201006), URL: http://psych.imng.com/fileadmin/content_pdf/cpn/archive_pdf/vol38iss6/70262_main.pdf, (20110610), XP008150642 DOI: http://dx.doi.org/10.1016/S0270-6644(10)70261-7 | Examination | WO2009021708 |